---

ECG Report Summary

Patient & Technical Details

• Paper speed: 25 mm/s | Gain: 10 mm/mV (standard settings)
• These are normal calibration values, meaning the tracing is reliable to interpret.

---

Automated Measurements

---

Step-by-Step ECG Interpretation

1. Rhythm

• Every QRS is preceded by a P wave
• P waves are upright in leads I, II, aVF (normal sinus origin)
• P wave is inverted in aVR (expected and normal)
• Regular P-P and R-R intervals

2. Rate: Mild Sinus Bradycardia (54-55 bpm)

• Young, fit, or athletic individuals (high vagal tone)
• Well-trained hearts at rest

3. Cardiac Axis: Normal (57°)

• QRS is positive in both Lead I and Lead aVF → axis falls in the normal quadrant (0° to +90°)
• No left or right axis deviation

4. Limb Lead Waveforms

• Lead I: Low-amplitude positive QRS, upright P and T - normal
• Lead II: Classic normal appearance - upright P, tall R, upright T
• Lead III: Small positive QRS, flat T - normal
• aVR: Inverted P, negative QRS, inverted T - all expected and normal
• aVL: Isoelectric QRS, flat T - normal
• aVF: Positive P, positive QRS, positive T - normal

5. Precordial (Chest) Leads V1-V6

• V1-V2: rS pattern (small r, deep S) - normal for right-sided leads
• V3: Transition zone - RS pattern
• V4-V6: Progressively taller R waves, upright T waves
• R-wave progression: Normal - gradual increase from V1 to V6, as expected

6. Intervals

• PR = 152 ms - Normal (rules out pre-excitation like WPW and heart block)
• QRS = 104 ms - Normal (rules out bundle branch block, which requires >120 ms)
• QTc = 356 ms - Normal (rules out long QT syndrome)

---

What is NOT Present (Reassuring Findings)

• No ST elevation (rules out acute MI/STEMI)
• No ST depression (rules out ischemia)
• No pathological Q waves (rules out old infarction)
• No T-wave inversions (rules out ischemia or strain)
• No bundle branch block (QRS is narrow)
• No pre-excitation (PR is normal)
• No delta waves

---

Notable Observation: Baseline Artifact

---

Overall Conclusion

This ECG is essentially normal for a 17-year-old male.

---

Disclaimer: This is an educational ECG explanation and not a medical diagnosis. For clinical interpretation and management, please consult the cardiologist or physician who ordered this test.

---

ECG Explanation - Shaik Ayan, 17M (14 Jul 2026)

What is an ECG?

---

Measurements at a Glance

---

The ECG Waveform - What Each Part Means

        R
        |
   P    |         T
   /\   |        /\
--/  \--|---\---/  \--
        |    \ /
        |     S
        Q

• P wave = atria (upper chambers) contracting to push blood into ventricles
• PR interval = electrical delay at the AV node (gives ventricles time to fill)
• QRS complex = ventricles (lower chambers) contracting to pump blood to lungs and body
• T wave = ventricles recovering (repolarizing) for the next beat
• QT interval = total time for ventricular activity (contraction + recovery)

---

Lead-by-Lead Findings

Limb Leads (I, II, III, aVR, aVL, aVF)

Chest (Precordial) Leads V1-V6

---

Key Findings

1. Sinus Bradycardia (54-55 bpm)

2. Normal Cardiac Axis (57°)

3. Normal QRS Width (104 ms)

4. Normal QTc (356 ms)

5. Baseline Artifact (Noise)

---

What is ABSENT (All Reassuring)

• No ST elevation - rules out heart attack (STEMI)
• No ST depression - rules out ischemia
• No pathological Q waves - rules out old infarction
• No T-wave inversions - rules out strain or ischemia
• No wide QRS - rules out bundle branch block
• No short PR or delta waves - rules out Wolff-Parkinson-White syndrome
• No prolonged QTc - rules out Long QT syndrome

---

Final Verdict

This is a normal ECG for a healthy 17-year-old male.

---

Disclaimer: This is an educational explanation only and does not constitute a medical diagnosis. Please consult the ordering physician or cardiologist for clinical interpretation and any follow-up decisions.

---

IV Chemotherapy Infusion Guide

Note: "Beviruzun" appears to be the brand name for Bevacizumab (anti-VEGF monoclonal antibody). The protocols below are based on standard international guidelines.

---

1. Inj. Beviruzun (Bevacizumab) 400 mg

• Do NOT administer within 28 days of major surgery
• Monitor for hypersensitivity/infusion reactions
• Stop infusion immediately if anaphylaxis occurs

---

2. Inj. Carboplatin 450 mg

• NEVER use aluminum-containing needles, syringes, or IV sets - aluminum reacts with carboplatin, forms black precipitate, and destroys the drug
• Use plastic/stainless steel equipment only
• Pre-hydration is generally not required (unlike cisplatin)
• Give anti-emetics before infusion (highly emetogenic)

---

3. Inj. Gemcitabine 1 gm

• Infusion time should NOT exceed 60 minutes - longer infusion times significantly increase toxicity (myelosuppression)
• Compatible with carboplatin in Y-site (can run through same line)

---

Recommended Administration Sequence

Step 1: Pre-medications (antiemetics, steroids if needed)
         ↓
Step 2: Inj. Gemcitabine 1g in 100 mL NS → over 30 min
         ↓
Step 3: Inj. Carboplatin 450mg in 250 mL NS → over 30-60 min
         ↓
Step 4: Inj. Beviruzun (Bevacizumab) 400mg in 100 mL NS → 90 min (1st cycle) / 60 min / 30 min
         ↓
Step 5: Flush line with NS after each drug

---

Quick Reference Summary

---

Disclaimer: This is for educational/reference purposes. Always verify doses, diluents, and infusion times against your institutional protocol, prescribing physician's orders, and current product monograph before administration. Chemotherapy must be prepared by a qualified oncology pharmacist under aseptic conditions.

Bevacizumab 400 mg in NS 500 mL - Is It Safe?

Direct Answer: ⚠️ NOT Recommended

---

Concentration Check (This is the Key)

Minimum: 1.4 mg/mL | Maximum: 16.5 mg/mL (Confirmed by Roche/Avastin EMA, MVASI, BC Cancer, and all major guidelines)

---

Why the Minimum Concentration Matters

• Bevacizumab is a monoclonal antibody - at concentrations below 1.4 mg/mL, the protein can become unstable, lose potency, or aggregate
• Diluting too much risks drug degradation and subtherapeutic dosing
• This is not a safety risk to the patient per se, but it compromises drug efficacy and is outside the validated stability range

---

Correct Practice

---

Bottom Line

Do NOT use 500 mL NS for Bevacizumab 400 mg. The resulting concentration (0.77 mg/mL) falls below the approved stability range of 1.4-16.5 mg/mL. Use 100 mL NS instead, infuse over 90 minutes for the first dose.

---

Disclaimer: Always follow your institutional pharmacy protocol and the oncologist's orders. Chemotherapy must be prepared by a qualified oncology pharmacist.

---

Next Cycle Protocol - Patient Tolerated 1st Dose Well ✅

---

1. Inj. Beviruzun (Bevacizumab) 400 mg

After 2nd dose, if still well tolerated → 3rd dose onwards = 30 minutes

---

2. Inj. Carboplatin 450 mg

Carboplatin infusion time does NOT step down - it stays at 30-60 min every cycle. No change needed.

---

3. Inj. Gemcitabine 1 gm

Gemcitabine always stays at 30 minutes - this does NOT reduce. Extending beyond 60 minutes increases toxicity.

---

Complete 2nd Cycle Schedule at a Glance

---

Only Bevacizumab Has the Step-Down Protocol

Dose 1  →  90 minutes  (1st infusion)
Dose 2  →  60 minutes  (if dose 1 tolerated) ← YOU ARE HERE
Dose 3+ →  30 minutes  (if dose 2 tolerated)

---

Reminder: Always pre-medicate with antiemetics before carboplatin. Watch for infusion reactions during bevacizumab (especially first 30 minutes). Keep emergency medications (adrenaline, hydrocortisone, antihistamine) at bedside during infusion.

Disclaimer: Follow your oncologist's orders and institutional protocol. This is for educational reference only.

---

Complete Infusion Sequence - Correct Order & Flushing

---

Step-by-Step Administration Order

PRE-MEDICATIONS FIRST (15-30 min before chemo)
        ↓
STEP 1 → Bevacizumab (Beviruzun)
        ↓
NS FLUSH
        ↓
STEP 2 → Gemcitabine
        ↓
NS FLUSH
        ↓
STEP 3 → Carboplatin
        ↓
NS FLUSH (end)

---

Detailed Protocol Table

---

Regarding NS Flush Between Each Drug

✅ YES - NS Flush is Required Between Every Drug

Why flush is needed:

• Clears the IV line completely of the previous drug
• Prevents drug-to-drug contact in the line (incompatibility risk)
• Ensures the full dose of each drug is delivered to the patient
• Protects the vein from drug residue

---

Why This Order (Bevacizumab First)?

---

Full Day Schedule (2nd Cycle - Patient Tolerated 1st Dose)

---

Key Reminders

• ⚠️ Never mix any two drugs in the same bag or give without flushing between
• ⚠️ No aluminum needles or lines for Carboplatin
• ⚠️ Keep emergency tray ready (adrenaline, hydrocortisone, antihistamine) during Bevacizumab infusion
• ✅ Monitor BP before and after Bevacizumab (it can cause hypertension)
• ✅ Monitor for signs of infusion reaction: flushing, rigors, hypotension, dyspnea

---

Disclaimer: This is for educational reference only. Always follow the oncologist's written orders and your institutional chemotherapy protocol. Chemotherapy administration must be supervised by a trained oncology nurse/physician.

NS Flush - 100 mL or 15-20 mL?

Direct Answer: 20 mL is the Minimum - But Purpose Matters

---

Two Types of Flush - Understand the Difference

Type 1 - Line Clearance Flush (Between Drugs)

A standard IV giving set holds approximately 15-25 mL of fluid in the tubing. So 20 mL minimum is needed just to clear the line itself.

---

Type 2 - Drug Completion Flush (End of Each Bag)

Research (PubMed 2023) showed that even after flushing, chemotherapy residue was still detectable in lines when small volumes were used. To achieve >50 mL rinse volume inside the line, you need at least 100 mL flush bag.

---

Practical Answer for Your Situation

---

What Most Oncology Centers Actually Do

---

Bottom Line - Simple Rule

✅ 20 mL NS syringe push = acceptable minimum to clear the line between drugs

✅ 100 mL NS fast drip = better practice, especially for central lines, ensures full dose delivered and line fully cleared

❌ 10 mL or less = NOT sufficient for chemotherapy lines - too little to clear tubing

---

For YOUR Three Drugs Specifically

---

Final Practical Answer: For your case - 20 mL NS syringe push is sufficient between these three drugs as they have no major incompatibility risk. However, if your institution protocol says 100 mL - follow that. Both are safe. 100 mL is the gold standard; 20 mL is the practical minimum.

Disclaimer: Follow your institutional chemotherapy nursing protocol. This is for educational reference only.

Time Gap Between Medicines

Direct Answer: No Mandatory Waiting Gap Required

---

The Only "Gap" is the Flush Itself

Bevacizumab finishes
        ↓
Flush NS 20 mL (2-3 min) ← This IS the gap
        ↓
Start Gemcitabine IMMEDIATELY
        ↓
Flush NS 20 mL (2-3 min) ← This IS the gap
        ↓
Start Carboplatin IMMEDIATELY

The flush time (2-5 minutes) is sufficient. No extra waiting needed.

---

When a Time Gap IS Required (Not Your Case)

---

Your Specific Situation - No Gap Needed Because:

---

Complete Timeline (No Gaps)

---

One Exception to Remember

⚠️ Always check patient vitals and do a quick assessment between drugs - not because a time gap is required, but because:

• BP check before Carboplatin (carboplatin can cause hypersensitivity within first few minutes)
• Ask patient: any dizziness, chest tightness, rash after Bevacizumab?
• This takes 2-3 minutes and is good nursing practice

---

Summary: Flush → Check patient → Start next drug immediately. No waiting time required between these three drugs.

---

Pre & Post Hydration - Bevacizumab + Gemcitabine + Carboplatin

---

Direct Answer

Bottom line: This regimen does NOT require mandatory IV hydration - unlike Cisplatin which always needs aggressive hydration. Carboplatin is much gentler on kidneys.

---

Why Carboplatin Does NOT Need Mandatory Hydration

Carboplatin was specifically designed to replace cisplatin because it does not need aggressive hydration.

---

What IS Recommended for Carboplatin

---

When Hydration WOULD Be Required

---

Standard Protocol for This Regimen

PRE-CHEMO:
✅ Check patient is well hydrated (orally)
✅ Check blood counts + renal function (creatinine/GFR)
✅ Give antiemetics (Ondansetron + Dexamethasone)
❌ No routine IV hydration bag needed

DURING CHEMO:
✅ Bevacizumab → Gemcitabine → Carboplatin
✅ NS flushes between drugs (20 mL)

POST-CHEMO:
✅ Encourage oral fluids at home (2-3 litres/day for 48 hrs)
✅ Take home antiemetics (Metoclopramide / Ondansetron)
❌ No routine post-hydration IV bag needed
⚠️ IF patient vomits or refuses oral fluids → give NS 500 mL before discharge

---

Contrast With Cisplatin (for your knowledge)

Cisplatin regimen (NOT your case):
- Pre-hydration: NS 1000 mL over 2-4 hrs MANDATORY
- Post-hydration: NS 1000 mL over 2-4 hrs MANDATORY
- Mannitol sometimes added to force diuresis
- Total fluids: 2-3 litres per day

Carboplatin regimen (YOUR case):
- Pre-hydration: NOT mandatory
- Post-hydration: NOT mandatory
- Just good oral intake + antiemetics

---

Final Answer

✅ No routine pre or post IV hydration required for Bevacizumab + Gemcitabine + Carboplatin regimen.

✅ Oral hydration (2-3 L/day for 48 hours after) is sufficient and should be advised to patient.

⚠️ Give IV hydration only if patient is clinically dehydrated, vomiting, elderly with poor renal function, or unable to take oral fluids.

---

Disclaimer: Always follow your oncologist's orders and institutional protocol. Some centers routinely add 500 mL NS pre/post as standard practice - follow your local guideline.

---

Bevacizumab 400 mg - Which NS Bag?

The Rule: Concentration Must Stay Between 1.4 - 16.5 mg/mL

---

Calculation for Each Bag Size

---

Final Answer

✅ Use NS 100 mL - This is the standard recommended bag

⚠️ NS 250 mL - Acceptable but borderline

❌ NS 500 mL - NOT safe, concentration falls below 1.4 mg/mL minimum

---

Simple Memory Rule

Bevacizumab 400 mg → Always NS 100 mL

This gives 3.4 mg/mL - safely within the 1.4-16.5 mg/mL approved range, and is the standard used in all NHS, EMA, and international oncology protocols.

---

Disclaimer: Follow your oncologist's orders and institutional pharmacy protocol.

ECG Explanation - MAIKAL, 37-Year-Old Male (09 Apr 2026)

---

Patient & Technical Details

---

Automated Measurements

---

What Each Wave Means

        R
        |
   P    |         T
   /\   |        /\
--/  \--|---\---/  \--
        |    \ /
        Q     S

---

Lead-by-Lead Analysis

Limb Leads

Chest Leads (Precordial)

---

What is ABSENT (All Reassuring)

---

Diagnosis Information Note

---

Final Conclusion

✅ This is a COMPLETELY NORMAL ECG

Normal sinus rhythm at 84 bpm in a 37-year-old male. All intervals, axis, waveforms, and morphology are within normal limits. No evidence of ischemia, infarction, arrhythmia, hypertrophy, or conduction disease.

---

Comparison with Previous ECG (Shaik Ayan, 17M)

---

Disclaimer: This is an educational ECG explanation only. Clinical interpretation and management decisions must be made by the treating physician or cardiologist.

ECG Explanation - Patient ID: 404315 (14 Jul 2026)

---

Patient & Technical Details

---

Automated Measurements

---

⚠️ KEY FINDING: SINUS TACHYCARDIA

Heart Rate = 109 bpm → This is SINUS TACHYCARDIA

• Every QRS is preceded by a normal P wave ✅
• P waves are upright in I, II, aVF ✅
• P wave is inverted in aVR ✅
• PR interval is normal (142 ms) ✅
• Rhythm is regular ✅

---

Lead-by-Lead Analysis

Limb Leads

Chest Leads (Precordial)

---

What is ABSENT (Reassuring)

---

About the QTcB = 453 ms (Borderline)

At a fast heart rate of 109 bpm, QTc calculation becomes less accurate. The Bazett formula overestimates QTc at high heart rates. This borderline value of 453 ms is likely a mathematical artefact of the fast rate - clinically not concerning in isolation.

---

Common Causes of Sinus Tachycardia

---

Final Conclusion

⚠️ SINUS TACHYCARDIA (109 bpm)

The ECG shows sinus tachycardia - the heart is beating fast but from the correct normal pacemaker. All waveforms, intervals, and morphology are otherwise within normal limits. No ischemia, infarction, block, or dangerous arrhythmia is present.

Action required: Find and treat the underlying cause of the tachycardia (fever, pain, dehydration, anaemia, anxiety, thyroid, etc.). The ECG itself does not show heart disease.

---

Comparison - All 3 ECGs Analyzed Today

---

Disclaimer: This is an educational ECG explanation only. Clinical interpretation and management must be done by the treating physician. Sinus tachycardia requires investigation of the underlying cause.

Clinical Analysis - Patient Sudha | Post-UTI Treatment Giddiness

---

First - Understand the Timeline

Last Month (June):
- Diagnosed: Cystitis + Umbilical Hernia (USG)
- Treatment given:
  → Inj. Monocef (Cefoperazone) 1gm IV BD × 3 days
  → IV Ciplox (Ciprofloxacin) × 2 days
  → Fosfomycin 3gm sachet × 1 dose (after finishing IV)

Now (July - 1 month later):
- Son calls: Mother has GIDDINESS

---

Most Likely Causes of Giddiness NOW (1 Month Later)

1. ⚠️ CIPROFLOXACIN TOXICITY - Most Important to Consider

⚠️ FDA Black Box Warning on Fluoroquinolones: Serious side effects including peripheral neuropathy, CNS effects, and tendon rupture can occur long after the drug is stopped - especially in elderly patients and women.

---

2. Possible Other Causes (Must Rule Out)

---

Questions to Ask the Son (Triage Over Phone)

---

Red Flag Symptoms - Send to Emergency IMMEDIATELY

❌ Sudden onset severe giddiness with headache ❌ Loss of consciousness or near-fainting ❌ Slurred speech, facial drooping, arm weakness → Stroke ❌ Chest pain with giddiness → Cardiac ❌ Very high or very low BP

---

Most Likely Scenario

Delayed fluoroquinolone (Ciprofloxacin) vestibular/CNS side effect

OR

Orthostatic hypotension in an elderly female post-illness

---

Recommended Action Plan

Immediate (Today):

1. Ask her to come for review - do not manage over phone
2. Check vitals: BP (lying and standing), pulse, temperature, SpO2
3. Check RBS (blood sugar)
4. Basic bloods if possible: CBC, electrolytes (Na, K), renal function

If Simple Giddiness / BPPV:

• Epley manoeuvre (if positional)
• Tab. Betahistine 16 mg BD × 1 week
• Reassurance

If Orthostatic Hypotension:

• Oral hydration
• Advice: rise slowly from bed
• Check if any BP medications being taken

If Fluoroquinolone Effect:

• Reassure - usually self-limiting
• Vitamin B complex (B1, B6, B12) supplementation
• Avoid further fluoroquinolones
• Refer neurologist if symptoms persist or worsen

If UTI Recurrence:

• Urine R/E and culture/sensitivity
• Appropriate antibiotic based on sensitivity (avoid fluoroquinolones again)

---

Note on Your Original Treatment

For future reference: In elderly women with cystitis, Fosfomycin alone (3gm single dose) is often sufficient as first-line and avoids fluoroquinolone risks. Ciprofloxacin is now generally not recommended as first-line for uncomplicated UTI in many guidelines due to its side effect profile and resistance concerns.

---

Summary

Patient Sudha's giddiness 1 month after treatment is most likely due to:

1. Delayed ciprofloxacin CNS/vestibular side effect (most likely)
2. Orthostatic hypotension (very common in elderly post-illness females)
3. BPPV (benign positional vertigo - common in this age group)

Call back the son, ask the screening questions above, and bring the patient in for review today.

---

Disclaimer: This is clinical educational guidance only. Final diagnosis and management must be based on direct patient assessment by the treating physician.